Top Markets
#1 MowCat MowCat +781.41%
#2 Islamic Coin Islamic Coin +152.09%
#3 龙虾 (Lobster) 龙虾 (Lobster) +85.82%
#4 Akedo Akedo +57.05%
#5 Magma Finance Magma Finance +42.91%
#6 MarsCoin MarsCoin +32.74%
#7 Pons Pons +32.28%
#8 SIXSEVEN SIXSEVEN +30.44%
#9 DeXe DeXe +27.75%
#10 Cortex Cortex +26.60%
Coin of the day
MowCat MowCat
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
LB Pharmaceuticals Inc Common Stock LB Pharmaceuticals Inc Common Stock

LB Pharmaceuticals Inc Common Stock

LBRX
Classement en actions #8002
This biopharmaceutical firm is currently in the clinical development stage,... This biopharmaceutical firm is currently in the clinical development stage, concentrating on the creation of innovative treatments for neuropsychiatric disorders such as schizophrenia and bipolar depression. Central to their pipeline is LB-102, their primary investigational drug, which is a methylated variant of amisulpride.
Prix de l'action
$48.45
Capitalisation boursière
$1.39B
Changement (1 jour)
1.16%
Changement (1 an)
-
Pays
US
Échange LB Pharmaceuticals Inc Common Stock (LBRX)

Catégorie

Healthcare
Ratio P/B pour LB Pharmaceuticals Inc Common Stock (LBRX)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de LB Pharmaceuticals Inc Common Stock, le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour LB Pharmaceuticals Inc Common Stock de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH